October 15, 2025

Study Describes Patterns in Reported Drug Interactions

Researchers analyze about 177,000 drug interactions to identify key medication safety trends.

Conexiant

October 07, 2025

FDA Announces New Development in Lung Care

The FDA has approved the first treatment in more than a decade for idiopathic pulmonary fibrosis.

Conexiant

October 03, 2025

Workplace Injury Gaps Emerged by Race

Data from 95 distinct occupations, along with imputed race and ethnicity, was used.

Conexiant

October 01, 2025

How Safe Are FDA-Cleared AI Tools?

“These findings indicate that standardized efficacy, safety, and risk assessment reporting remains inadequate for FDA-cleared AI/ML devices, underscoring the need for dedicated regulatory pathways and robust postmarket surveillance to ensure patient safety."

Conexiant

September 29, 2025

FDA Expands Options for Pediatric Psoriasis, PsA

The FDA has approved the first IL-23 inhibitor for pediatric patients with plaque psoriasis and psoriatic arthritis.

Conexiant

September 23, 2025

Juvenile SLE: Feasibility of Early Glucocorticoid Tapering

Early glucocorticoid tapering in juvenile systemic lupus erythematosus is feasible without added flare risk, though anti-double-stranded DNA positivity signals higher relapse odds.

Conexiant

September 19, 2025

Seizurelike Spells Unmask Encephalitis

A 19-year-old woman presents with recurrent seizurelike episodes, mutism, and psychosis. Imaging is unrevealing, but cerebrospinal fluid analysis and pelvic imaging uncover the diagnosis.

Conexiant

September 18, 2025

'Integrity Cannot Be Replaced': Ousted CDC Leader Speaks Out

Testimony from former CDC leadership highlighted differences with federal health officials on the process for reviewing and implementing vaccine policies.

KFF Health News

September 18, 2025

Cuts or Care: ‘What Are the Priorities?’

New residency programs launch as Northern California faces ongoing physician shortages and potential funding reductions.

KFF Health News